{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:39:09Z","timestamp":1791189549394,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.antiviral.2014.11.001","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T16:12:05Z","timestamp":1415722325000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"special_numbering":"C","title":["The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection"],"prefix":"10.1016","volume":"113","author":[{"given":"Christopher","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Sliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"von Rhein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate M.","family":"K\u00fcmmerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Schnierle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.antiviral.2014.11.001_b0005","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm.2105","article-title":"A virus-like particle vaccine for epidemic chikungunya virus protects nonhuman primates against infection","volume":"16","author":"Akahata","year":"2010","journal-title":"Nat. Med."},{"issue":"7513","key":"10.1016\/j.antiviral.2014.11.001_b0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/512124a","article-title":"US assesses virus of the Caribbean","volume":"512","author":"Bajak","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.antiviral.2014.11.001_b0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ng1366","article-title":"Plzf is required in adult male germ cells for stem cell self-renewal","volume":"36","author":"Buaas","year":"2004","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.antiviral.2014.11.001_b0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/hep.24803","article-title":"(\u2212)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry","volume":"55","author":"Calland","year":"2012","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.antiviral.2014.11.001_b0025","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00705-012-1304-0","article-title":"(\u2212)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus","volume":"157","author":"Chen","year":"2012","journal-title":"Arch. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2014.11.001_b0030","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/hep.24610","article-title":"The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry","volume":"54","author":"Ciesek","year":"2011","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.antiviral.2014.11.001_b0035","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1128\/JVI.00896-14","article-title":"A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans","volume":"88","author":"Colpitts","year":"2014","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2014.11.001_b0040","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/00002030-200204120-00020","article-title":"Polyphenolic antioxidant (\u2212)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent","volume":"16","author":"Fassina","year":"2002","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.antiviral.2014.11.001_b0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.antiviral.2013.08.002","article-title":"Inhibition of influenza virus internalization by (\u2212)-epigallocatechin-3-gallate","volume":"100","author":"Kim","year":"2013","journal-title":"Antiviral Res."},{"issue":"5","key":"10.1016\/j.antiviral.2014.11.001_b0050","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1128\/JCM.03109-12","article-title":"Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection","volume":"51","author":"Kishishita","year":"2013","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.antiviral.2014.11.001_b0055","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.2014.9916","article-title":"Chikungunya virus transmission found in the United States: US health authorities brace for wider spread","volume":"312","author":"Kuehn","year":"2014","journal-title":"JAMA"},{"issue":"Pt 9","key":"10.1016\/j.antiviral.2014.11.001_b0060","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1099\/vir.0.043752-0","article-title":"Construction of an infectious chikungunya virus cDNA clone and stable insertion of mCherry reporter genes at two different sites","volume":"93","author":"K\u00fcmmerer","year":"2012","journal-title":"J. Gen. Virol."},{"issue":"17","key":"10.1016\/j.antiviral.2014.11.001_b0065","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.phytochem.2006.06.020","article-title":"Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives","volume":"67","author":"Nagle","year":"2006","journal-title":"Phytochemistry"},{"issue":"12","key":"10.1016\/j.antiviral.2014.11.001_b0070","doi-asserted-by":"crossref","first-page":"e1003835","DOI":"10.1371\/journal.ppat.1003835","article-title":"Genome-wide RNAi screen identifies novel host proteins required for alphavirus entry","volume":"9","author":"Ooi","year":"2013","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.antiviral.2014.11.001_b0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2009.07.013","article-title":"Characterization of chikungunya pseudotyped viruses: identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein","volume":"393","author":"Salvador","year":"2009","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.antiviral.2014.11.001_b0080","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bph.12009","article-title":"Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea","volume":"168","author":"Steinmann","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.antiviral.2014.11.001_b0085","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrrheum.2012.64","article-title":"Arthritogenic alphaviruses[mdash]an overview","volume":"8","author":"Suhrbier","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"12","key":"10.1016\/j.antiviral.2014.11.001_b0090","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1371\/journal.ppat.0030201","article-title":"A single mutation in chikungunya virus affects vector specificity and epidemic potential","volume":"3","author":"Tsetsarkin","year":"2007","journal-title":"PLoS Pathog."},{"issue":"7324","key":"10.1016\/j.antiviral.2014.11.001_b0095","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.antiviral.2014.11.001_b0100","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1586\/erv.12.84","article-title":"Chikungunya virus and prospects for a vaccine","volume":"11","author":"Weaver","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2014.11.001_b0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2014.02.001","article-title":"A neutralization assay for chikungunya virus infections in a multiplex format","volume":"201","author":"Weber","year":"2014","journal-title":"J. Virol. Methods"},{"issue":"6","key":"10.1016\/j.antiviral.2014.11.001_b0110","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2006.08.016","article-title":"Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy","volume":"118","author":"Williamson","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.antiviral.2014.11.001_b0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-3542(01)00189-9","article-title":"Inhibitory effects of (\u2212)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1)","volume":"53","author":"Yamaguchi","year":"2002","journal-title":"Antiviral Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T23:38:53Z","timestamp":1572305933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214003118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":23,"alternative-id":["S0166354214003118"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.11.001","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}